Witnessing the stock’s movement on the chart, on Thursday, BioAffinity Technologies Inc (NASDAQ: BIAF) set off with pace as it heaved 25.83% to $3.41, before settling in for the price of $2.71 at the close. Taking a more long-term approach, BIAF posted a 52-week range of $2.34-$67.12.
It was noted that the giant of the Healthcare sector posted annual sales growth of -10.71% over the last 5 years. Meanwhile, its Annual Earning per share during the time was -10.71%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 36.00%. This publicly-traded company’s shares outstanding now amounts to $0.95 million. The organization now has a market capitalization sitting at $15.34 million. At the time of writing, stock’s 50-day Moving Average stood at $5.91, while the 200-day Moving Average is $12.03.
BioAffinity Technologies Inc (BIAF) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Diagnostics & Research industry. BioAffinity Technologies Inc’s current insider ownership accounts for 0.00%, in contrast to 2.88% institutional ownership.
BioAffinity Technologies Inc (BIAF) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.7 per share during the current fiscal year.
BioAffinity Technologies Inc’s EPS increase for this current 12-month fiscal period is 36.00% and is forecasted to reach -8.10 in the upcoming year.
BioAffinity Technologies Inc (NASDAQ: BIAF) Trading Performance Indicators
Let’s observe the current performance indicators for BioAffinity Technologies Inc (BIAF). It’s Quick Ratio in the last reported quarter now stands at 0.63. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.00.
In the same vein, BIAF’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -20.98, a figure that is expected to reach -2.70 in the next quarter, and analysts are predicting that it will be -8.10 at the market close of one year from today.
Technical Analysis of BioAffinity Technologies Inc (BIAF)
Going through the that latest performance of [BioAffinity Technologies Inc, BIAF]. Its last 5-days volume of 4.47 million indicated improvement to the volume of 1.07 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 50.38% While, its Average True Range was 49.16.
Raw Stochastic average of BioAffinity Technologies Inc (BIAF) in the period of the previous 100 days is set at 8.45%, which indicates a major fall in contrast to 40.99% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.47 that was lower than 1.00 volatility it exhibited in the past 100-days period.
